PPARD and fatty liver disease: PPAR-α agonist treatment of control rats increased the intensity of Oil red O staining (Figure 3B), whereas treatments with the PPAR-δ agonist strikingly reduced Oil red O staining, and therefore hepatic steatosis (Figure 3C).